Current Study Trials

Amgen: Injec­tion treat­ment for mod­er­ate to severe Atopic Der­mati­tis / Eczema.

Acrotech: Top­i­cal treat­ment for mild to mod­er­ate Atopic Der­mati­tis / Eczema.

Bris­tol Myers Squib (BMS): Oral or injec­tion for mild to mod­er­ate Plaque Psoriasis.

Cara Ther­a­peu­tics: Oral with top­i­cal treat­ment for mild to mod­er­ate Atopic Der­mati­tis / Eczema with severe itch.

Incyte: Top­i­cal treat­ment for mild, mod­er­ate, or severe Pruri­go Nodularis.

Eli Lil­ly: Oral treat­ment for mod­er­ate to severe Alope­cia Area­ta for ages 6 to 17.

Moberg: Top­i­cal treat­ment for mild to mod­er­ate Ony­chomy­co­sis / Toe­nail fungus.

Pfiz­er: Oral treat­ment for Non-seg­men­tal Vitiligo.

Sanofi: Injec­tion treat­ment for mod­er­ate to severe Asth­ma in adults.

Sci­ence 37: Screen­ing blood draw for ear­ly detec­tion of Col­orec­tal Cancer.

Teva: Inhala­tion treat­ment for asth­ma with a severe exac­er­ba­tion in chil­dren and adults.

If you have any ques­tions regard­ing any of the tri­als list­ed here, please do not hes­i­tate to con­tact us at 574−204−6192 or research@​southbendclinic.​com.